Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

Danish biopharma giant Novo Nordisk (NOV: N) is breaking new ground with its GLP-1 agonist semaglutide, as a small mid-stage ...

The researchers also showed the capsule worked with an Ozempic-like weight-loss drug ... As well as helping people who don't like needles, it could mean that drug doses can be kept to a minimum ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

In an important regulatory win for Denmark’s Novo Nordisk, the US Food and Drug Administration (FDA) yesterday approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening, kidney ...

Anne-Marie Zanzal, 60, and her wife Tonda McKay, 62, have also experienced the more positive changes that weight-loss drugs ...

Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

An advert for the company’s power stretch denim leggings has been banned by the Advertising Standards Agency (ASA) for the ...

Dr. Maya Green discusses HIV prevention, U=U, and the importance of regular testing, particularly addressing disparities affecting Black women in healthcare.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as effective as bariatric surgery.